We have some really exciting assets that can bring a lot of value upon clinical success - that is not to say that the price cant be volatile. If we cap raise around these prices after results because of macros etc we will see prices get smashed even more.. this could be the new top. I don't mind as ill be buying up more XD
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-19188
-
- There are more pages in this discussion • 746 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online